ImmunoPrecise Antibodies Ltd [IPA] stock prices are up 8.36% to $0.56 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The IPA shares have gain 2.94% over the last week, with a monthly amount glided 38.86%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
ImmunoPrecise Antibodies Ltd [NASDAQ: IPA] stock has seen the most recent analyst activity on December 02, 2022, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $9. Previously, The Benchmark Company started tracking the stock with Buy rating on October 25, 2021, and set its price target to $12.
The stock price of ImmunoPrecise Antibodies Ltd [IPA] has been fluctuating between $0.32 and $2.60 over the past year. ImmunoPrecise Antibodies Ltd [NASDAQ: IPA] shares were valued at $0.56 at the most recent close of the market.
Analyzing the IPA fundamentals
The ImmunoPrecise Antibodies Ltd [NASDAQ:IPA] reported sales of 17.69M for trailing twelve months, representing a drop of -0.98%. Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at -0.55%, Pretax Profit Margin comes in at -1.25%, and Net Profit Margin reading is -1.14%. To continue investigating profitability, this company’s Return on Assets is posted at -0.46, Equity is -0.74 and Total Capital is -0.28. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.5.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.5100 points at the first support level, and at 0.4600 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.6000, and for the 2nd resistance point, it is at 0.6400.
Ratios To Look Out For
It’s worth pointing out that ImmunoPrecise Antibodies Ltd [NASDAQ:IPA]’s Current Ratio is 1.01. On the other hand, the Quick Ratio is 0.85, and the Cash Ratio is 0.28. Considering the valuation of this stock, the price to sales ratio is 0.98, the price to book ratio is 0.72.
